The cannabis industry continues to show mixed results across key U.S. markets, with notable developments in California, Massachusetts, and New Mexico. While California leads in tax revenue, both Massachusetts and New Mexico face slight declines in sales, reflecting broader market shifts. Get Benzinga’s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here . You can't afford to miss out if you’re serious about the business. Massachusetts: A Saturated Market? In Massachusetts, legal cannabis sales totaled $152 million in November 2024, a 1% decrease from October but a 4% increase from November 2023. On a quarter-to-date basis, sales totaled $305 million for October and November, marking a 5% decline from the prior quarter. The average price per gram fell to $4.58, the lowest since 2020. Average revenue per dispensary dropped to $362k/month (down 2% from the prior month and 8% year-over-year). Notable companies operating in Massachusetts include AYR Wellness AYRWF , Curaleaf CURLF and Green Thumb Industries GTBIF , contributing to this market's competitive landscape. “The average price per gram was $4.58 in November, the lowest since we began tracking in January 2020. There were 379 operating dispensaries at the end of November, indicating an average revenue of $362k per dispensary (or approximately $4.3M/year). We note that this is down 2% m/m and 8% y/y from $4.7M/year (or $394k) in November 2023, with the decline attributable to the addition of 53 dispensaries y/y,” reads a recent report from Beacon Securities . New Mexico New Mexico's cannabis market showed slight sales fluctuations in November, with total sales of $48 million, down 2% from October but up 3% from the previous year. Quarter-to-date sales were $96 million, a 5% decrease from the July-August period. The average revenue per dispensary remained stable at approximately $70k/month. Notably, Schwazze SHWZ is a key player in the state, contributing to the overall market dynamics. Adult-use transactions averaged $39, while medical cannabis sales averaged $48 per transaction. Read Also: Ho-Ho-Holy Smokes! Record Weed Sales Drive Dispensaries To Stock Smart This Holiday Season California: Strong Q3 Revenue Despite Declining Cultivation Tax California's cannabis tax revenue for the third quarter of 2024 reached $250.5 million, with $148.4 million from excise taxes and $102 million from sales tax. This brings the state's total cannabis tax revenue since 2018 to over $6.5 billion . Revenue from cannabis excise taxes supports a range of programs, including childcare, medical research, and youth substance abuse prevention. Despite the elimination of the cultivation tax in July 2022, the market remains a significant financial contributor to the state. Read Next: Illinois Cannabis Sales Back On Track In October Hitting $142.3M After Slight September Dip © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.By Ja'han Jones Artificial intelligence is helping spread dubious and even outright false claims on social media, empowering propagandists and misinformation peddlers in new ways. Experts in the field are now discussing ways to address that. That makes Texas Sen. Ted Cruz mad. Not about the propaganda. About the people trying to stop it. Cruz wrote a letter in November to Attorney General Merrick Garland that was published this week , demanding that the Department of Justice probe “how Europeans are seeking to hamstring US AI development.” Now, Europeans aren’t actually trying to hamstring U.S. A.I. development, but in the letter, Cruz refers to a November summit the Biden administration hosted in San Francisco for several countries that — along with the United States — have launched their own “A.I. safety institutes” to combat the dangers of artificial intelligence. Cruz’s letter alleges that one of the summit’s participants, an Oxford-based nonprofit called the Centre for the Governance of Artificial Intelligence, is essentially acting as an unregistered foreign agent because the group has provided guidance to U.S. lawmakers about how to combat dangerous misuses of artificial intelligence. The letter fits a pattern of right-wingers fuming over efforts to stem the tide of dangerous online content that's intended to deceive or manipulate the public. True to form, Cruz portrayed the U.K. AI safety institute and the Centre for the Governance of Artificial Intelligence’s work as nefarious: AI has vast potential to improve human welfare and society. But some technocrats and academics believe AI poses severe “risks” to “safety,” which they define as “disinformation,” “bias and underrepresentation,” and “risks to the environment.” Hence, they want governments to globally adopt enforceable “standards” that would empower unelected bureaucrats to actively oversee AI developers and products, and censor disfavored code and AI-generated material. For the record, all of the things Cruz mentioned are real problems — and putting them in scare quotes doesn't change that. The senator went on to claim the aforementioned European-led groups are talking about their A.I. concerns “not just to gain control over AI’s development, but to also gain control over information flow and a citizen’s ability to communicate with others free from government intrusion.” This was a dizzying spin from Cruz, considering the most powerful technocrats in the world — Elon Musk and Mark Zuckerberg , for example — seem willing to allow false or deceptive content to pervade their social platforms, and in Musk’s case, willing to use this manipulative content to his advantage . These are the controlling technocrats worthy of our worries. Nonetheless, Cruz’s letter includes Musk’s Orwellian falsehood that “[w]hen a politician says they want to stop 'misinformation' what they really mean is that they want to stop anyone from contradicting their lies.” As The Associated Press explained , the November summit’s agenda “address[ed] topics such as how to better detect and combat a flood of AI-generated deepfakes fueling fraud, harmful impersonation and sexual abuse.” And Commerce Secretary Gina Raimondo seemed to undercut Cruz’s kvetching at the conference when she said the U.S. AI institute is not a regulatory body — and thus, incapable of enforcing anything — and also “not in the business of stifling innovation.” But I think the source of Cruz’s angst is clear. Republicans leaned heavily on A.I.-generated propaganda and A.I.-powered social media algorithms to help spread dubious (at times, outright false) claims this election cycle. And anyone seen as a potential threat to similar efforts in the future is deemed an enemy of the party — if not the nation as a whole. Ja'han Jones is The ReidOut Blog writer. He's a futurist and multimedia producer focused on culture and politics. His previous projects include "Black Hair Defined" and the "Black Obituary Project."
Tottenham manager Postecoglou cops flak from angry fans
Bains meets Gadkari, seeks 4-lane road from Kiratpur Sahib to Una
The people that president-elect Donald Trump has selected to lead federal health agencies in his second administration include a retired congressman, a surgeon and a former talk-show host. All of them could play pivotal roles in fulfilling a new political agenda that could change how the government goes about safeguarding Americans' health — from health care and medicines to food safety and science research. And if Congress approves, at the helm of the team as Department of Health and Human Services secretary will be prominent environmental lawyer and anti-vaccine organizer Robert F. Kennedy Jr. By and large, the nominees don't have experience running large bureaucratic agencies, but they know how to talk about health on TV . Centers for Medicare and Medicaid pick Dr. Mehmet Oz hosted a talk show for 13 years and is a well-known wellness and lifestyle influencer. The pick for the Food and Drug Administration, Dr. Marty Makary, and for surgeon general, Dr. Janette Nesheiwat, are frequent Fox News contributors. Many on the list were critical of COVID-19 measures like masking and booster vaccinations for young people. Some of them have ties to Florida like many of Trump's other Cabinet nominees: CDC pick Dr. Dave Weldon represented the state in Congress for 14 years and is affiliated with a medical group on the state's Atlantic coast. Nesheiwat's brother-in-law is Rep. Mike Waltz , R-Fla., tapped by Trump as national security adviser. Here's a look at the nominees' potential role in carrying out what Kennedy says is the task to “reorganize” agencies, which have an overall $1.7 billion budget; employ 80,000 scientists, researchers, doctors and other officials; and affect the lives of all Americans. Centers for Disease Control and Prevention The Atlanta-based CDC, with a $9.2 billion core budget, is charged with protecting Americans from disease outbreaks and other public health threats. Kennedy has long attacked vaccines and criticized the CDC, repeatedly alleging corruption at the agency. He said on a 2023 podcast that there is "no vaccine that is safe and effective,” and urged people to resist the CDC's guidelines on if and when kids should get vaccinated . Decades ago, Kennedy found common ground with Weldon , the 71-year-old nominee to run the CDC who served in the Army and worked as an internal medicine doctor before he represented a central Florida congressional district from 1995 to 2009. Starting in the early 2000s, Weldon had a prominent part in a debate about whether there was a relationship between a vaccine preservative called thimerosal and autism. He was a founding member of the Congressional Autism Caucus and tried to ban thimerosal from all vaccines. Kennedy, then a senior attorney for the Natural Resources Defense Council, believed there was a tie between thimerosal and autism and also charged that the government hid documents showing the danger. Since 2001, all vaccines manufactured for the U.S. market and routinely recommended for children 6 years or younger have contained no thimerosal or only trace amounts, with the exception of inactivated influenza vaccine. Meanwhile, study after study after study found no evidence that thimerosal caused autism. Weldon's congressional voting record suggests he may go along with Republican efforts to downsize the CDC, including to eliminate the National Center for Injury Prevention and Control, which works on topics like drownings, drug overdoses and shooting deaths. Weldon also voted to ban federal funding for needle-exchange programs as an approach to reduce overdoses, and the National Rifle Association gave him an “A” rating for his pro-gun rights voting record. Food and Drug Administration Kennedy is extremely critical of the FDA, which has 18,000 employees and is responsible for the safety and effectiveness of prescription drugs, vaccines and other medical products — as well as overseeing cosmetics, electronic cigarettes and most foods. Makary, Trump’s pick to run the FDA, is closely aligned with Kennedy on several topics . The professor at Johns Hopkins University who is a trained surgeon and cancer specialist has decried the overprescribing of drugs, the use of pesticides on foods and the undue influence of pharmaceutical and insurance companies over doctors and government regulators. Kennedy has suggested he'll clear our “entire” FDA departments and also recently threatened to fire FDA employees for “aggressive suppression” of a host of unsubstantiated products and therapies, including stem cells, raw milk , psychedelics and discredited COVID-era treatments like ivermectin and hydroxychloroquine. Makary's contrarian views during the COVID-19 pandemic including the need for masking and giving young kids COVID vaccine boosters. But anything Makary and Kennedy might want to do when it comes to unwinding FDA regulations or revoking long-standing vaccine and drug approvals would be challenging. The agency has lengthy requirements for removing medicines from the market, which are based on federal laws passed by Congress. Centers for Medicaid and Medicare Services The agency provides health care coverage for more than 160 million people through Medicaid, Medicare and the Affordable Care Act, and also sets Medicare payment rates for hospitals, doctors and other providers. With a $1.1 trillion budget and more than 6,000 employees, Oz has a massive agency to run if confirmed — and an agency that Kennedy hasn't talked about much when it comes to his plans. While Trump tried to scrap the Affordable Care Act in his first term, Kennedy has not taken aim at it yet. But he has been critical of Medicaid and Medicare for covering expensive weight-loss drugs — though they're not widely covered by either . Trump said during his campaign that he would protect Medicare, which provides insurance for older Americans. Oz has endorsed expanding Medicare Advantage — a privately run version of Medicare that is popular but also a source of widespread fraud — in an AARP questionnaire during his failed 2022 bid for a U.S. Senate seat in Pennsylvania and in a 2020 Forbes op-ed with a former Kaiser Permanente CEO. Oz also said in a Washington Examiner op-ed with three co-writers that aging healthier and living longer could help fix the U.S. budget deficit because people would work longer and add more to the gross domestic product. Neither Trump nor Kennedy have said much about Medicaid, the insurance program for low-income Americans. Trump's first administration reshaped the program by allowing states to introduce work requirements for recipients. Surgeon general Kennedy doesn't appear to have said much publicly about what he'd like to see from surgeon general position, which is the nation's top doctor and oversees 6,000 U.S. Public Health Service Corps members. The surgeon general has little administrative power, but can be an influential government spokesperson on what counts as a public health danger and what to do about it — suggesting things like warning labels for products and issuing advisories. The current surgeon general, Vivek Murthy, declared gun violence as a public health crisis in June. Trump's pick, Nesheiwat, is employed as a New York City medical director with CityMD, a group of urgent care facilities in the New York and New Jersey area, and has been at City MD for 12 years. She also has appeared on Fox News and other TV shows, authored a book on the “transformative power of prayer” in her medical career and endorses a brand of vitamin supplements. She encouraged COVID-19 vaccines during the pandemic, calling them “a gift from God” in a February 2021 Fox News op-ed, as well as anti-viral pills like Paxlovid. In a 2019 Q&A with the Women in Medicine Legacy Foundation , Nesheiwat said she is a “firm believer in preventive medicine” and “can give a dissertation on hand-washing alone.” National Institutes of Health As of Saturday, Trump had not yet named his choice to lead the National Institutes of Health, which funds medical research through grants to researchers across the nation and conducts its own research. It has a $48 billion budget. Kennedy has said he'd pause drug development and infectious disease research to shift the focus to chronic diseases. He'd like to keep NIH funding from researchers with conflicts of interest, and criticized the agency in 2017 for what he said was not doing enough research into the role of vaccines in autism — an idea that has long been debunked . ___ Associated Press writers Amanda Seitz and Matt Perrone and AP editor Erica Hunzinger contributed to this report. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content. Mike Stobbe, The Associated PressCitigroup Issues Positive Forecast for Huntington Bancshares (NASDAQ:HBAN) Stock Price
NoneCELH Investors Have Opportunity to Lead Celsius Holdings, Inc. Securities Fraud Lawsuit
An aerial view of the aftermath of an overnight strike attributed to Israel on the Barzeh scientific research centre affiliated with the Syrian defence ministry in northern Damascus on 10 December 2024. (Omar HAJ KADOUR / AFP) Israel said it had hit Syria more than 350 times since the fall of President Bashar al-Assad, wiping out strategic weapons and infrastructure. It would not let those weapons fall into the hands of jihadists, said Prime Minister Benjamin Netanyahu. Israel aims to permanently retain what it calls a defensive buffer in southern Syria. Israel aims to impose a "sterile defence zone" in southern Syria that would be enforced without a permanent troop presence, defence minister Israel Katz said on Tuesday, as the military said a wave of air strikes had destroyed the bulk of Syria's strategic weapons stockpiles. Over the past 48 hours, following the collapse of the government of President Bashar al-Assad, the military said jets had conducted more than 350 strikes on targets including anti-aircraft batteries, military airfields, weapons production sites, combat aircraft and missiles. In addition, missile vessels struck the Syrian naval facilities of Al-Bayda port and Latakia port, where 15 Syrian naval vessels were docked. Israeli officials said the strikes across Syria were aimed at destroying strategic weapons and military infrastructure to prevent them being used by rebel groups that drove Assad from power, some of which grew from movements linked to al Qaeda and Islamic State. "We have no intention of interfering in Syria's internal affairs, but we clearly intend to do what is necessary to ensure our security," Prime Minister Benjamin Netanyahu said. "I authorised the air force to bomb strategic military capabilities left by the Syrian army, so that they would not fall into the hands of the jihadists." Following Assad's flight on Sunday, Israeli troops moved into the demilitarised zone inside Syria created after the 1973 Arab-Israeli war, including the Syrian side of the strategic Mount Hermon that overlooks Damascus, where it took over an abandoned Syrian military post. A military spokesperson said Israeli troops remained in the buffer zone as well as "a few additional points" in the vicinity. But he denied that forces had penetrated Syrian territory significantly beyond the area, after a Syrian source said they had reached the town of Qatana, several km (miles) to the east of the zone and just a short drive from Damascus airport. "IDF forces are not advancing towards Damascus. This is not something we are doing or pursuing in any way," Lieutenant Colonel Nadav Shoshani, the military spokesperson, told a briefing with reporters. 'Temporary, limited measure' Israel, which has just agreed to a ceasefire in Lebanon following weeks of fighting the Iranian-backed Hezbollah movement, calls the incursion into Syrian territory a limited and temporary measure to ensure border security. But the scale of the Israeli strikes echoed a similar wave of attacks in southern Lebanon in September that destroyed a significant quantity of Hezbollah's missile stocks. According to the Israeli military the strikes hit most of the strategic weapons stockpiles in Syria as well as production sites in the cities of Damascus, Homs, Tartus, Latakia and Palmyra. Scud and cruise missiles as well as sea-to-sea missiles, drones, launchers and firing positions were destroyed, it said in a statement. Strikes against military airfields and bases also destroyed Syrian military attack helicopters, fighter jets and tanks. Israel welcomed the fall of Assad, an ally of its main enemy Iran, but has reacted cautiously to the leading rebel faction, Hayat Tahrir al-Sham. HTS has roots in Islamist movements including al Qaeda and Islamic State though it has sought for years to moderate its image. Katz gave no details of the "sterile defence zone" Israel aims to impose in southern Syria but the extent of the operation underlined the power of its air force. "We want relations with the new regime in Syria," Netanyahu said but added that if Iranian weapons were transferred through Syria to Hezbollah or if Israel were attacked "we will respond forcefully and we will exact a heavy price". We live in a world where facts and fiction get blurred Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered. Join News24 today Related Links 'Suddenly everyone was scared': Assad flees Syria, PM promises to co-operate with new leadership Russia vows 'appropriate and palpable' response to US weapons fired by Ukraine Syrian rebels capture key city of Hama in fresh blow to Assad, Iran, and Russia
Trump names Andrew Ferguson as head of Federal Trade Commission to replace Lina KhanBritish Columbia Premier David Eby says Canada’s premiers and the federal government have hatched a game plan over possible U.S. tariffs, where Conservative premiers lobby their Republican counterparts and left-leaning leaders court the Democrats, while the federal government focuses on president-elect Donald Trump. Eby says the premiers and Prime Minister Justin Trudeau talked about using their political diversity and connections to approach politicians and business leaders in the United States, as talks over Trump’s proposed 25 per cent tariff on imports from Canada and Mexico ramp up. He says it has been discussed that Conservative premiers Danielle Smith in Alberta, Doug Ford in Ontario and Nova Scotia’s Tim Houston are well-placed to lobby their contacts with Republican governors and business leaders. In a year-end interview, Eby says as a New Democrat leader he will likely have more in common speaking with Democrat governors and business leaders from the West Coast states. He says Canada’s diversity of representation, ranging from the right and left sides of the political spectrum, can bring leverage and advantages in tariff talks. Eby also says — if it is deemed helpful — he is prepared to appear on American’s right-leaning Fox News TV network as did premiers Ford and Smith.
None
Nokia Corporation Stock Exchange Release 4 December 2024 at 22:30 EET Nokia Corporation: Repurchase of own shares on 04.12.2024 Espoo, Finland – On 4 December 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: * Rounded to two decimals On 22 November 2024, Nokia announced that its Board of Directors is initiating a share buyback program to offset the dilutive effect of new Nokia shares issued to the shareholders of Infinera Corporation and certain Infinera Corporation share-based incentives. The repurchases in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 3 April 2024 started on 25 November 2024 and end by 31 December 2025 and target to repurchase 150 million shares for a maximum aggregate purchase price of EUR 900 million. Total cost of transactions executed on 4 December 2024 was EUR 3,502,064. After the disclosed transactions, Nokia Corporation holds 209,033,034 treasury shares. Details of transactions are included as an appendix to this announcement. On behalf of Nokia Corporation BofA Securities Europe SA About Nokia At Nokia, we create technology that helps the world act together. As a B2B technology innovation leader, we are pioneering networks that sense, think and act by leveraging our work across mobile, fixed and cloud networks. In addition, we create value with intellectual property and long-term research, led by the award-winning Nokia Bell Labs. With truly open architectures that seamlessly integrate into any ecosystem, our high-performance networks create new opportunities for monetization and scale. Service providers, enterprises and partners worldwide trust Nokia to deliver secure, reliable and sustainable networks today – and work with us to create the digital services and applications of the future. Inquiries: Nokia Communications Phone: +358 10 448 4900 Email: press.services@nokia.com Maria Vaismaa, Global Head of External Communications Nokia Investor Relations Phone: +358 40 803 4080 Email: investor.relations@nokia.com Attachment Daily Report 2024-12-04